| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.99▼ | 1.98▼ | 1.97▲ | 2.04▼ | 2.35▼ |
| MA10 | 1.99▼ | 1.97▲ | 1.99▼ | 2.24▼ | 2.06▼ |
| MA20 | 1.98▲ | 1.98▼ | 2.01▼ | 2.29▼ | 2.02▼ |
| MA50 | 2.02▼ | 2.13▼ | 2.23▼ | 1.99▼ | 1.57▲ |
| MA100 | 2.21▼ | 2.27▼ | 2.32▼ | 2.01▼ | 1.11▲ |
| MA200 | 2.31▼ | 2.25▼ | 2.04▼ | 1.76▲ | 1.46▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.013▲ | 0.011▲ | -0.068▼ | 0.010▲ |
| RSI | 45.903▼ | 41.134▼ | 37.394▼ | 43.611▼ | 50.229▲ |
| STOCH | 44.669 | 63.535 | 39.881 | 14.680▼ | 82.264▲ |
| WILL %R | -50.000 | -45.455 | -57.143 | -88.372▼ | -48.718 |
| CCI | -33.079 | 11.999 | -27.009 | -130.146▼ | 27.604 |
|
Friday, December 19, 2025 08:44 AM
(RTTNews) - IN8bio, Inc. (INAB), said on Friday, a biopharmaceutical company that's currently in clinical stages and working on T cell therapies for cancer and autoimmune diseases announced it had ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 1.97 | 2.03 | 1.87 | 1.97 | 36,330 |
| 29/01/26 | 1.96 | 2.05 | 1.91 | 2.00 | 63,152 |
| 28/01/26 | 2.09 | 2.17 | 1.96 | 1.96 | 66,458 |
| 27/01/26 | 2.18 | 2.255 | 2.05 | 2.07 | 57,415 |
| 26/01/26 | 2.33 | 2.40 | 2.20 | 2.20 | 85,917 |
| 23/01/26 | 2.49 | 2.50 | 2.40 | 2.40 | 53,745 |
| 22/01/26 | 2.36 | 2.53 | 2.31 | 2.48 | 30,990 |
| 21/01/26 | 2.37 | 2.54 | 2.30 | 2.33 | 59,469 |
| 20/01/26 | 2.58 | 2.6148 | 2.36 | 2.36 | 136,955 |
| 16/01/26 | 2.31 | 2.73 | 2.265 | 2.59 | 236,622 |
|
|
||||
|
|
||||
|
|